Rapid Micro Biosystems In... (RPID)
undefined
undefined%
At close: undefined
1.00
3.12%
After-hours Dec 13, 2024, 03:57 PM EST

Company Description

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia.

The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services.

Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables.

The company also provides installation and verification, technical training, and support services.

Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications.

The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007.

Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc. logo
Country United States
IPO Date Jul 15, 2021
Industry Medical - Devices
Sector Healthcare
Employees 193
CEO Robert G. Spignesi Jr.

Contact Details

Address:
1001 Pawtucket Boulevard West
Lowell, Massachusetts
United States
Website https://www.rapidmicrobio.com

Stock Details

Ticker Symbol RPID
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001380106
CUSIP Number 75340L104
ISIN Number US75340L1044
Employer ID 00-0000000
SIC Code 3826

Key Executives

Name Position
Robert G. Spignesi Jr. Chief Executive Officer, President & Director
John J. Addington Wilson Chief Operating Officer
Sean M. Wirtjes CPA Chief Financial Officer
James Xu Vice President of Legal & Secretary
Kristine Williams Senior Vice President of Product
Michael Beaulieu C.F.A. Vice President of Investor Relations & Corporate Communications
Michael Wysocki Senior Vice President of Sales & Marketing

Latest SEC Filings

Date Type Title
Dec 05, 2024 4 Filing
Nov 27, 2024 4 Filing
Nov 12, 2024 8-K Current Report
Nov 07, 2024 10-Q Quarterly Report
Nov 01, 2024 8-K Current Report
Aug 09, 2024 4 Filing
Aug 08, 2024 4 Filing
Aug 07, 2024 4 Filing
Aug 07, 2024 4 Filing
Aug 02, 2024 10-Q Quarterly Report